Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-02 8:26 pm Sale | 2026-06-30 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 1,985,541 4.100% | -930,201 (-31.90%) | Filing History |
| 2026-06-26 5:39 pm Sale | 2026-06-24 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 2,915,742 6.000% | -738,565 (-20.21%) | Filing History |
| 2026-06-24 6:49 pm Purchase | 2026-06-22 | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 12,036,126 11.900% | 2,722,370 (+29.23%) | Filing History |
| 2026-06-22 7:02 pm Sale | 2026-06-17 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 3,654,307 7.500% | -1,484,396 (-28.89%) | Filing History |
| 2026-06-18 4:09 pm Purchase | 2026-06-11 | 13D | PARABILIS MEDICINES INC PBLS | RA CAPITAL MANAGEMENT L.P. | 28,933,371 23.800% | 28,933,371 (New Position) | Filing History |
| 2026-06-15 8:16 pm Sale | 2026-06-11 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 5,138,703 10.600% | -977,437 (-15.98%) | Filing History |
| 2026-06-15 7:37 pm Purchase | 2026-06-11 | 13D | ARTIVA BIOTHERAPEUTICS INC ARTV | RA CAPITAL MANAGEMENT L.P. | 17,811,623 36.600% | 1,434,155 (+8.76%) | Filing History |
| 2026-06-04 5:01 pm Purchase | 2026-05-28 | 13G | Q32 BIO INC QTTB | RA CAPITAL MANAGEMENT L.P. | 2,332,457 9.800% | 2,332,457 (New Position) | Filing History |
| 2026-06-03 4:45 pm Purchase | 2026-05-27 | 13G | EDITAS MEDICINE INC EDIT | RA CAPITAL MANAGEMENT L.P. | 8,889,000 5.800% | 8,889,000 (New Position) | Filing History |
| 2026-05-21 9:12 pm Purchase | 2026-05-14 | 13G | SANA BIOTECHNOLOGY INC SANA | RA CAPITAL MANAGEMENT L.P. | 18,750,000 6.300% | 18,750,000 (New Position) | Filing History |
| 2026-05-15 4:47 pm Purchase | 2026-03-31 | 13G | VAXCYTE INC PCVX | RA CAPITAL MANAGEMENT L.P. | 12,974,599 8.900% | 10,108 (+0.08%) | Filing History |
| 2026-05-15 4:45 pm Purchase | 2026-03-31 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA CAPITAL MANAGEMENT L.P. | 2,801,082 9.900% | 415,803 (+17.43%) | Filing History |
| 2026-05-15 4:43 pm Purchase | 2026-03-31 | 13G | PALISADE BIO INC COM P PALI | RA CAPITAL MANAGEMENT L.P. | 17,620,479 9.900% | 1,873,650 (+11.90%) | Filing History |
| 2026-05-15 4:42 pm Sale | 2026-03-31 | 13G | INVIVYD, INC. IVVD | RA CAPITAL MANAGEMENT L.P. | 21,342,442 7.000% | -7,514,766 (-26.04%) | Filing History |
| 2026-05-15 4:40 pm Unchanged | 2026-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA CAPITAL MANAGEMENT L.P. | 2,611,733 4.800% | 0 (Unchanged) | Filing History |
| 2026-05-15 4:38 pm Sale | 2026-03-31 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | RA CAPITAL MANAGEMENT L.P. | 1,296,012 4.000% | -883,699 (-40.54%) | Filing History |
| 2026-05-15 4:36 pm Sale | 2026-03-31 | 13G | AVIDITY BIOSCIENCES INC RNAM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -8,641,031 (Position Closed) | Filing History |
| 2026-05-15 4:34 pm Purchase | 2026-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | RA CAPITAL MANAGEMENT L.P. | 2,455,655 9.900% | 516,590 (+26.64%) | Filing History |
| 2026-05-15 4:32 pm Purchase | 2026-03-31 | 13G | ATRIUM THERAPEUTICS INC RNA | RA CAPITAL MANAGEMENT L.P. | 864,102 5.600% | 864,102 (New Position) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA CAPITAL MANAGEMENT L.P. | 5,105,622 9.900% | -608,230 (-10.64%) | Filing History |